FDA Investigator Brian Janelsins, PhD
Brian Janelsins, PhD has inspections in 1 countries as of 10 Feb 2023. Brian Janelsins, PhD has collaborated with a combinined 628 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
10 Feb 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Andrew "Drew" Haack, PhD,
Andrew Haack, PhD,
Andrew K Haack, PhD,
Anita Narula, PhD,
Barbara Janine Breithaupt,
CDR Donald Ertel,
Charles Yuanchia Kuo, PhD,
Chava Kimchi Sarfaty, PhD,
Christopher R Czajka,
Deborah M Trout,
Joan Johnson,
Kathryn E King,
Lisa K Capron,
Michael S Araneta,
Mihaly S Ligmond,
Mikhail V Ovanesov, PhD,
Nataniel Phillips Sylvain, PhD,
Prabhu P Raju,
Rabia Ballica, PhD,
Richard Ledwidge (nmi), PhD,
Riley C Myers, PhD,
Riley Meyers,
S Lori Brown, PhD MPH,
Teegan Dellibovi Ragheb, PhD,
V Teres Speer,
Vanessa Y Gelsey, PhD,
Vanessa Y Jacobs,
Wayne E Seifert,
Yideng Liang,
Yuan Chia Kuo,
Zhong Li, PhD
Brian Janelsins, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2023 | EIR | AGC Biologics, Inc. - EIR, 2023-09-18 |
February, 2023 | FDA 483 | AGC Biologics, Inc. - Form 483, 2023-02-10 |
December, 2023 | FDA 483 | Human Genome Sciences, Inc. - Form 483, 2023-12-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more